{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "50881-026",
      "generic_name": "pemigatinib",
      "labeler_name": "Incyte Corporation",
      "brand_name": "PEMAZYRE",
      "active_ingredients": [
        {
          "name": "PEMIGATINIB",
          "strength": "4.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "50881-026-01",
          "description": "14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01)",
          "marketing_start_date": "20200417",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Incyte Corporation"
        ],
        "rxcui": [
          "2359334",
          "2359340",
          "2359342",
          "2359344",
          "2359346",
          "2359348"
        ],
        "spl_set_id": [
          "9e1f2222-1d89-4e63-989c-ccebe2ab1eb4"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175605",
          "N0000175082",
          "N0000185503",
          "N0000187061",
          "N0000191423"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Kinase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]",
          "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
        ],
        "unii": [
          "Y6BX7BL23K"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200417",
      "product_id": "50881-026_7ab778c9-5f92-4e53-bfe8-8db8d3bd3ef3",
      "application_number": "NDA213736",
      "brand_name_base": "PEMAZYRE",
      "pharm_class": [
        "Kinase Inhibitor [EPC]",
        "Kinase Inhibitors [MoA]",
        "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
        "Organic Cation Transporter 2 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}